Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Netelenbos

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2006
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis]W F Lems, N A T Hamdy, J C Netelenbos
Nederlands Tijdschrift Voor Tandheelkunde|May 1, 1995
[Osteoporosis and jaw bone reduction]M A van Waas, F G Corten, J C Netelenbos
The American Journal of Cardiology|March 1, 1987
Hypercalcemia and J wavesJ C Netelenbos, F W Verheugt, S H de Rijk
Nederlands Tijdschrift Voor Geneeskunde|December 23, 1978
[Hypercalciuria and kidney calculi]J C Netelenbos, W A Haagsma-Schouten, E Lopes Cardozo
American Journal of Epidemiology|December 1, 1990
Re: "Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment"D Beijerinck, K Hopian, P A van Noord, et al.
Annals of Internal Medicine|October 1, 1990
Corticosteroids and bone massH E van der Wiel, C H Polman, J C Netelenbos
Clinical Nephrology|March 25, 2005
Risk factors determining active urinary stone formation in patients with urolithiasisJ C Netelenbos, P J G Zwijnenburg, P M ter Wee
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexualsP Lips, H Asscheman, P Uitewaal, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patientsW H Hackeng, P Lips, J C Netelenbos, et al.
Bone and Mineral|December 1, 1993
Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidismL van Doorn, P Lips, J C Netelenbos, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2006
[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis]W F Lems, N A T Hamdy, J C Netelenbos
Nederlands Tijdschrift Voor Tandheelkunde|May 1, 1995
[Osteoporosis and jaw bone reduction]M A van Waas, F G Corten, J C Netelenbos
The American Journal of Cardiology|March 1, 1987
Hypercalcemia and J wavesJ C Netelenbos, F W Verheugt, S H de Rijk
Nederlands Tijdschrift Voor Geneeskunde|December 23, 1978
[Hypercalciuria and kidney calculi]J C Netelenbos, W A Haagsma-Schouten, E Lopes Cardozo
American Journal of Epidemiology|December 1, 1990
Re: "Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment"D Beijerinck, K Hopian, P A van Noord, et al.
Annals of Internal Medicine|October 1, 1990
Corticosteroids and bone massH E van der Wiel, C H Polman, J C Netelenbos
Clinical Nephrology|March 25, 2005
Risk factors determining active urinary stone formation in patients with urolithiasisJ C Netelenbos, P J G Zwijnenburg, P M ter Wee
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexualsP Lips, H Asscheman, P Uitewaal, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patientsW H Hackeng, P Lips, J C Netelenbos, et al.
Bone and Mineral|December 1, 1993
Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidismL van Doorn, P Lips, J C Netelenbos, et al.
Pageof 12